german chancellor angela merkel (bottom left) was straightforward when she said enlargment was not on the table at the sofia summit .
.
.
the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid.
.
.
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful
.